On this page:OverviewFunded papers
ScholarIQanswers from OpenAlex

Amicus Therapeutics

FunderResearch funding and supported work

Amicus Therapeutics is a funder indexed in ScholarIQ from OpenAlex.

What is known about Amicus Therapeutics?

ScholarIQrecord summary

company in Cranbury, United States

How many works does Amicus Therapeutics have?

ScholarIQindexed works

Amicus Therapeutics has 1,440 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Amicus Therapeutics?

ScholarIQopenalex

The OpenAlex for Amicus Therapeutics is on the source record.

What is the ROR of Amicus Therapeutics?

ScholarIQror

The ROR for Amicus Therapeutics is on the source record.

What are the most-cited papers on Amicus Therapeutics?

ScholarIQmost cited works
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan M. Mejía‐Vilet, Carla Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan‐Stephan Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney Tang, Vladimı́r Tesař, Marina Vivarelli, Jack F.M. Wetzels, Lyubov Lytvyn, Jonathan C. Craig, David J. Tunnicliffe, Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Jürgen Floege
Kidney International. 2021804 CitationsOPEN ACCESS
470M+ articles · 14-day free trial